• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Social and legal factors related to drug abuse in the United States and Japan.美国和日本与药物滥用相关的社会及法律因素。
Public Health Rep. 1994 Nov-Dec;109(6):731-7.
2
Summary of an eleven-country study of socio-legal measures to combat drug abuse and related crime.一项关于打击药物滥用及相关犯罪的社会法律措施的十一个国家研究的总结。
Bull Narc. 1984 Jul-Sep;36(3):3-8.
3
Recent trends of drug abuse in Japan.日本药物滥用的近期趋势。
Ann N Y Acad Sci. 2004 Oct;1025:430-8. doi: 10.1196/annals.1316.053.
4
Japan: stimulant epidemics past and present.
Bull Narc. 1989;41(1-2):83-93.
5
The history and current state of drug abuse in Japan.日本药物滥用的历史和现状。
Ann N Y Acad Sci. 2011 Jan;1216:62-72. doi: 10.1111/j.1749-6632.2010.05914.x.
6
[Current situation of and the political measures for drug abuse/dependence].[药物滥用/依赖的现状及政策措施]
Nihon Arukoru Yakubutsu Igakkai Zasshi. 2008 Apr;43(2):120-31.
7
Comparison of drug abuse in Germany and China.德国与中国药物滥用情况的比较。
Acta Pharmacol Sin. 2007 Oct;28(10):1505-18. doi: 10.1111/j.1745-7254.2007.00633.x.
8
Drug abuse in Asia.亚洲的药物滥用问题。
Bull Narc. 1986 Jan-Jun;38(1-2):41-53.
9
Drug-related crime and sentencing policies from the perspective of the United Nations crime prevention and criminal justice programme.从联合国预防犯罪和刑事司法方案角度看与毒品相关的犯罪及量刑政策。
Bull Narc. 1984 Jul-Sep;36(3):47-57.
10
A cross-national comparison of risk and protective factors for adolescent substance use: the United States and Australia.青少年物质使用风险与保护因素的跨国比较:美国和澳大利亚
J Adolesc Health. 2004 Jul;35(1):3-16. doi: 10.1016/j.jadohealth.2003.08.015.

引用本文的文献

1
Perceptions of barriers and facilitators to opioid reduction after total joint arthroplasty among orthopedic surgeons practicing in Canada, Japan, and the Netherlands: A qualitative description study.加拿大、日本和荷兰的骨科医生对全关节置换术后减少阿片类药物使用的障碍和促进因素的看法:一项定性描述性研究。
PLoS One. 2025 Aug 29;20(8):e0331335. doi: 10.1371/journal.pone.0331335. eCollection 2025.
2
Opioid use in postoperative pain management of pediatric appendectomy patients in Japan.日本小儿阑尾切除术后疼痛管理中阿片类药物的使用情况。
J Anesth. 2025 Jun 14. doi: 10.1007/s00540-025-03525-7.
3
Challenges and limitations of the existing scoring systems for postoperative outcomes in thoracolumbar pyogenic spondylitis: a multicenter retrospective cohort study.胸腰椎化脓性脊柱炎术后结局现有评分系统的挑战与局限性:一项多中心回顾性队列研究
Eur Spine J. 2025 May 17. doi: 10.1007/s00586-025-08933-7.
4
Newly estimated disability weights for 196 health states in Hubei Province, China.中国湖北省196种健康状态的最新残疾权重估计值。
Popul Health Metr. 2024 Dec 18;22(1):37. doi: 10.1186/s12963-024-00359-5.
5
Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.依酚氯胺治疗甲基苯丙胺使用障碍:一项探索性、随机、双盲、安慰剂对照试验。
Neuropsychopharmacol Rep. 2022 Mar;42(1):92-104. doi: 10.1002/npr2.12232. Epub 2022 Jan 23.
6
Reduced carboxylesterase 1 is associated with endothelial injury in methamphetamine-induced pulmonary arterial hypertension.羧酸酯酶1水平降低与甲基苯丙胺诱导的肺动脉高压中的内皮损伤有关。
Am J Physiol Lung Cell Mol Physiol. 2017 Aug 1;313(2):L252-L266. doi: 10.1152/ajplung.00453.2016. Epub 2017 May 4.
7
Evaluation of the "Pipeline" for Development of Medications for Cocaine Use Disorder: A Review of Translational Preclinical, Human Laboratory, and Clinical Trial Research.可卡因使用障碍药物研发“管道”评估:转化临床前、人体实验室及临床试验研究综述
Pharmacol Rev. 2016 Jul;68(3):533-62. doi: 10.1124/pr.115.011668.
8
Brain Histamine N-Methyltransferase As a Possible Target of Treatment for Methamphetamine Overdose.脑组胺N-甲基转移酶作为甲基苯丙胺过量治疗的潜在靶点
Drug Target Insights. 2016 Mar 2;10:1-7. doi: 10.4137/DTI.S38342. eCollection 2016.
9
Combination pharmacotherapies for stimulant use disorder: a review of clinical findings and recommendations for future research.兴奋剂使用障碍的联合药物治疗:临床研究结果综述及未来研究建议。
Expert Rev Clin Pharmacol. 2014 May;7(3):363-74. doi: 10.1586/17512433.2014.909283. Epub 2014 Apr 9.
10
Agonist replacement for stimulant dependence: a review of clinical research.兴奋剂依赖的激动剂替代:临床研究综述。
Curr Pharm Des. 2013;19(40):7026-35. doi: 10.2174/138161281940131209142843.

本文引用的文献

1
Prevalence of volatile solvent inhalation among junior high school students in Japan and background life style of users.
Addiction. 1993 Jan;88(1):89-100. doi: 10.1111/j.1360-0443.1993.tb02766.x.
2
The opiate trade of Taiwan and Japan: an historical note.
J Psychoactive Drugs. 1981 Jan-Mar;13(1):35-8. doi: 10.1080/02791072.1981.10471448.
3
Opium availability and the prevalence of addiction in Asia.
Br J Addict. 1981 Mar;76(1):85-90. doi: 10.1111/j.1360-0443.1981.tb00210.x.
4
A birds eye view of the present state of drug abuse in Japan.
Drug Alcohol Depend. 1983 Feb;11(1):55-6. doi: 10.1016/0376-8716(83)90095-9.
5
Relationship of consumers' perceptions of drugs to drug use.消费者对药物的认知与药物使用之间的关系。
Public Health Rep. 1983 Jan-Feb;98(1):85-90.
6
Over-the-counter drugs: factors in adult use of sedatives, tranquilizers, and stimulants.非处方药:成人使用镇静剂、安定药和兴奋剂的相关因素。
Public Health Rep. 1984 May-Jun;99(3):319-23.
7
Mexican-American heroin addicts.墨西哥裔美国海洛因成瘾者。
Am J Drug Alcohol Abuse. 1984;10(3):317-46. doi: 10.3109/00952998409001475.
8
Drug abuse and counter-measures in Japan.日本的药物滥用与应对措施。
Med J Malaysia. 1974 Dec;29(2):136-44.
9
Drug abuse in Asia.亚洲的药物滥用问题。
Bull Narc. 1986 Jan-Jun;38(1-2):41-53.
10
Drug abuse and prevention programs in 29 countries.
Int J Addict. 1988 Jan;23(1):1-17. doi: 10.3109/10826088809027487.

美国和日本与药物滥用相关的社会及法律因素。

Social and legal factors related to drug abuse in the United States and Japan.

作者信息

Greberman S B, Wada K

机构信息

Addiction Research Center, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD 21224.

出版信息

Public Health Rep. 1994 Nov-Dec;109(6):731-7.

PMID:7800780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1403573/
Abstract

This article is an overview of social and legal differences in the United States and in Japan that are related to patterns of current drug abuse epidemics in these countries. These two nations have drug abuse problems with different histories and take different approaches currently to handling illicit drug marketing and use. Histories of opiate and cocaine abuse in the United States and of stimulant and inhalant abuse in Japan are discussed. The United States has experienced three heroin epidemics in the last three decades; cocaine addiction began to merit national concern by the end of the 1980s. In Japan, the first methamphetamine epidemic began after World War II; it was controlled in the 1950s. The current inhalant epidemic began in the late 1960s and was followed by the second methamphetamine epidemic that began in 1970; both are continuing to the present. The criminal justice system is always given first consideration when assessing societal measures employed to reduce drug use. Legal penalties for illicit drug offenses reflect the societal differences of these two nations with respect to the seriousness of particular types of crimes. Characteristics of the health care system of a nation may also influence patterns of drug abuse, particularly where functions of criminal justice and health care systems overlap. Health care systems in the United States and in Japan are based on different treatment philosophies and patients' expectations; these differences are discussed along with explanations of their potential influence on the epidemiology of drug abuse.

摘要

本文概述了美国和日本在社会及法律方面的差异,这些差异与这两个国家当前的药物滥用流行模式相关。这两个国家有着不同历史的药物滥用问题,且目前在处理非法药物销售和使用方面采取不同的方法。文中讨论了美国的阿片类药物和可卡因滥用历史以及日本的兴奋剂和吸入剂滥用历史。美国在过去三十年里经历了三次海洛因流行;到20世纪80年代末,可卡因成瘾开始引起全国关注。在日本,第一次甲基苯丙胺流行始于第二次世界大战后;在20世纪50年代得到控制。当前的吸入剂流行始于20世纪60年代末,随后是始于1970年的第二次甲基苯丙胺流行;两者至今仍在持续。在评估为减少药物使用而采取的社会措施时,刑事司法系统总是被优先考虑。对非法药物犯罪的法律处罚反映了这两个国家在特定类型犯罪严重性方面的社会差异。一个国家医疗保健系统的特点也可能影响药物滥用模式,特别是在刑事司法系统和医疗保健系统职能重叠的地方。美国和日本的医疗保健系统基于不同的治疗理念和患者期望;文中讨论了这些差异以及它们对药物滥用流行病学潜在影响的解释。